Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BLRX

Bioline Rx Ltd ADR

Apr 30 • 04:00PM ET

2.75

-0.32 -10.42 %

Healthcare • Biotechnology • Israel • Nano • NASD

Peers: BPMC ARGX MGNX ONCY AFMD ADAP IMMP KPTI CTMX FATE

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.18	Insider Own	0.56%	Shs Outstand	4.35M	Perf Week	19.57%
Market Cap	11.96M	Forward P/E	-	EPS next Y	-0.34	Insider Trans	0.00%	Shs Float	4.33M	Perf Month	19.56%
Enterprise Value	6.38M	PEG	-	EPS next Q	-1.04	Inst Own	1.10%	Short Float	3.57%	Perf Quarter	-13.25%
Income	-1.30M	P/S	10.05	EPS this Y	-	Inst Trans	11.66%	Short Ratio	9.58	Perf Half Y	-25.27%
Sales	1.19M	P/B	0.66	EPS next Y	39.09%	ROA	-3.25%	Short Interest	0.15M	Perf YTD	-0.72%
Book/sh	4.18	P/C	0.57	EPS next 5Y	-	ROE	-8.19%	52W High	7.77 -64.61%	Perf Year	-20.75%
Cash/sh	4.80	P/FCF	-	EPS past 3/5Y	75.30% 66.78%	ROIC	-5.49%	52W Low	2.15 27.91%	Perf 3Y	-93.57%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	36.15%	Volatility	13.17% 6.98%	Perf 5Y	-97.81%
Dividend TTM	-	EV/Sales	5.36	EPS Y/Y TTM	96.05%	Oper. Margin	-871.39%	ATR (14)	0.22	Perf 10Y	-99.53%
Dividend Ex-Date	-	Quick Ratio	1.78	Sales Y/Y TTM	-95.92%	Profit Margin	-109.15%	RSI (14)	59.33	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.95	EPS Q/Q	78.83%	SMA20	15.42%	Beta	1.51	Target Price	17.50
Payout	-	Debt/Eq	0.56	Sales Q/Q	-98.35%	SMA50	8.71%	Rel Volume	4.78	Prev Close	3.07
Employees	24	LT Debt/Eq	0.30	Earnings	Mar 23 BMO	SMA200	-15.74%	Avg Volume	16.15K	Price	2.75
IPO	Jul 25, 2011	Option/Short	Yes / Yes	EPS/Sales Surpr.	29.87% -62.26%	Trades		Volume	77,193	Change	-10.42%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)